Axogen (FRA:LT3) Cyclically Adjusted FCF per Share: €-0.52 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LT3 Axogen Inc FRA:LT3
64 GF Score
Price €33.53
GF Value €12.86
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Axogen Cyclically Adjusted FCF per Share?

Axogen FRA:LT3 +1.54% 64 Cyclically Adjusted FCF per Share is €-0.52 as of Mar. 2026. GuruFocus rates FRA:LT3 with a GF Score™ of 64/100 and a GF Value™ of €12.86 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Axogen's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.023. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.52 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Axogen was 14.50% per year. The lowest was -66.00% per year. And the median was -6.40% per year.

As of today (2026-07-20), Axogen's current stock price is €33.53. Axogen's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.52. Axogen's Cyclically Adjusted Price-to-FCF of today is .


Axogen  (FRA:LT3) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Axogen Cyclically Adjusted FCF per Share Related Terms


Axogen Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Axogen's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen Cyclically Adjusted FCF per Share Chart

Axogen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.64 -0.74 -0.66 -0.66 -0.55

Axogen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.56 -0.54 -0.55 -0.52

FRA:LT3 vs TMDX, BFLY, ESTA: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Axogen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Axogen's Cyclically Adjusted Price-to-FCF falls into.


FRA:LT3
64GF Score
Axogen Inc FRA:LT3
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Axogen Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Axogen's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.023/330.2130*330.2130
=-0.023

Current CPI (Mar. 2026) = 330.2130.

Axogen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.085 241.018 -0.116
201609 -0.077 241.428 -0.105
201612 -0.054 241.432 -0.074
201703 -0.117 243.801 -0.158
201706 -0.065 244.955 -0.088
201709 -0.062 246.819 -0.083
201712 -0.038 246.524 -0.051
201803 -0.149 249.554 -0.197
201806 -0.105 251.989 -0.138
201809 -0.188 252.439 -0.246
201812 -0.118 251.233 -0.155
201903 -0.213 254.202 -0.277
201906 -0.165 256.143 -0.213
201909 -0.092 256.759 -0.118
201912 -0.102 256.974 -0.131
202003 -0.301 258.115 -0.385
202006 -0.341 257.797 -0.437
202009 -0.070 260.280 -0.089
202012 -0.009 260.474 -0.011
202103 -0.290 264.877 -0.362
202106 -0.183 271.696 -0.222
202109 -0.204 274.310 -0.246
202112 -0.186 278.802 -0.220
202203 -0.362 287.504 -0.416
202206 -0.225 296.311 -0.251
202209 -0.125 296.808 -0.139
202212 -0.121 296.797 -0.135
202303 -0.263 301.836 -0.288
202306 -0.094 305.109 -0.102
202309 -0.050 307.789 -0.054
202312 -0.042 306.746 -0.045
202403 -0.290 312.332 -0.307
202406 0.062 314.175 0.065
202409 0.057 315.301 0.060
202412 0.164 315.605 0.172
202503 -0.283 319.799 -0.292
202506 0.120 322.561 0.123
202509 0.024 324.800 0.024
202512 0.020 324.054 0.020
202603 -0.023 330.213 -0.023

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.52 mean?
Axogen (FRA:LT3) has a Cyclically Adjusted FCF per Share of €-0.52 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Axogen and its competitors.
Is Axogen's Cyclically Adjusted FCF per Share too high?
Axogen's current Cyclically Adjusted FCF per Share is €-0.52. Overall, Axogen has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Cyclically Adjusted FCF per Share compare to TMDX and BFLY?
Axogen's Cyclically Adjusted FCF per Share of €-0.52 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Axogen and its competitors. Axogen's current Cyclically Adjusted FCF per Share is €-0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (FRA:LT3) is currently considered Significantly Overvalued. The stock's GF Value™ is €12.86, compared to a current price of €33.53 — trading 160.7% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.52. Axogen's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Axogen (FRA:LT3), the current Cyclically Adjusted FCF per Share is €-0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (FRA:LT3) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of €33.53 is trading 160.7% above its estimated GF Value™ of €12.86. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for FRA:LT3:

  • Cyclically Adjusted FCF per Share: €-0.52
  • GF Value™: €12.86 vs. price of €33.53 (160.7% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the FRA:LT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Axogen Business Description

Other Exchanges AXGN:USA0HKD:UKLT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
64GF Score

Get the complete analysis for FRA:LT3

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€33.53
Price
€12.86
GF Value